Labopharm Announces its Once-Daily Tramadol Approved for Sale in Canada.

M2 PRESSWIRE-18 June 2007-Morning Movers: Labopharm Announces its Once-Daily Tramadol Approved for Sale in Canada(C)1994-2007 M2 COMMUNICATIONS LTD RDATE:18062007 Market Gainer is quickly emerging as the one stop shop for international small-cap investors looking to stay a step ahead of the markets. Activity on the Toronto market has brought this company to the attention of our research team. Labopharm Inc. (TSX: DDS), is responding to the attention of investors. Our goal is to create a community of international investors who consistently and effectively capitalize on the ...